Preclinical and Phase I Randomized Study of a Potent Inhalable Nanobody Targeting TSLP for the Treatment of Airway Inflammation

Journal:
The Journal of Allergy and Clinical Immunology
Published:
DOI:
10.1016/j.jaci.2025.06.024
Affiliations:
2
Authors:
10
Go to article
Institutions Authors Share
Novamab, China
9.000000
 0.90
Shanghai University of Medicine and Health Sciences (SUMHS), China
1.000000
 0.10
Interested in Immunology?